Paola Papaldo
Division of Medical Oncology A
Regina Elena Cancer Institute
Via Elio Chianesi 53
00144 Rome
Italy
Name/email consistency: high
- Is anthracycline-based chemotherapy alone adequate for young women with estrogen receptor-positive breast cancer?. Papaldo, P., Di Cosimo, S., Ferretti, G., Carlini, P., Fabi, A., Cecere, F., Cognetti, F. Breast (2006)
- Impact of five prophylactic filgrastim schedules on hematologic toxicity in early breast cancer patients treated with epirubicin and cyclophosphamide. Papaldo, P., Lopez, M., Marolla, P., Cortesi, E., Antimi, M., Terzoli, E., Vici, P., Barone, C., Ferretti, G., Di Cosimo, S., Carlini, P., Nisticò, C., Conti, F., Di Lauro, L., Botti, C., Di Filippo, F., Fabi, A., Giannarelli, D., Calabresi, F. J. Clin. Oncol. (2005)
- Addition of either lonidamine or granulocyte colony-stimulating factor does not improve survival in early breast cancer patients treated with high-dose epirubicin and cyclophosphamide. Papaldo, P., Lopez, M., Cortesi, E., Cammilluzzi, E., Antimi, M., Terzoli, E., Lepidini, G., Vici, P., Barone, C., Ferretti, G., Di Cosimo, S., Nistico, C., Carlini, P., Conti, F., Di Lauro, L., Botti, C., Vitucci, C., Fabi, A., Giannarelli, D., Marolla, P. J. Clin. Oncol. (2003)
